(Q37349765)

19 August 2017

Prednisolone improves walking in Japanese Duchenne muscular dystrophy patients (English)

1 reference

Duchenne muscular dystrophy

19 August 2017

1 reference

En Kimura

10

0 references

Ichizo Nishino

object named as

Ichizo Nishino

8

0 references

Madoka Mori-Yoshimura

6

object named as

Madoka Mori-Yoshimura

1 reference

19 August 2017

3

Harumasa Nakamura

1 reference

19 August 2017

11

Shin'ichi Takeda

1 reference

19 August 2017

5

Hirofumi Komaki

1 reference

19 August 2017

2

Naohiro Yonemoto

1 reference

19 August 2017

Fumi Takeuchi

1

1 reference

19 August 2017

Reiko Shimizu

4

1 reference

19 August 2017

Yukiko K Hayashi

7

1 reference

19 August 2017

Mitsuru Kawai

9

1 reference

19 August 2017

22 September 2013

1 reference

19 August 2017

1 reference

19 August 2017

260

1 reference

19 August 2017

12

1 reference

19 August 2017

3023-3029

1 reference

Creative Commons Attribution 2.0 Generic

19 August 2017

start time

22 September 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s00415-013-7104-y

0 references

cites work

The TREAT-NMD Duchenne muscular dystrophy registries: conception, design, and utilization by industry and academia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843366

The cooperative international neuromuscular research group Duchenne natural history study--a longitudinal investigation in the era of glucocorticoid therapy: design of protocol and the methods used

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843366

Characteristics of Japanese Duchenne and Becker muscular dystrophy patients in a novel Japanese national registry of muscular dystrophy (Remudy).

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843366

Novel approaches to corticosteroid treatment in Duchenne muscular dystrophy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843366

Drug treatment of Duchenne muscular dystrophy: available evidence and perspectives

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843366

Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843366

Creatine for treating muscle disorders

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843366

Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843366

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843366

A review of nutrition in Duchenne muscular dystrophy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843366

Glucocorticoid corticosteroids for Duchenne muscular dystrophy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843366

Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843366

Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843366

Dystrophin and mutations: one gene, several proteins, multiple phenotypes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843366

Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843366

Prednisolone in Duchenne muscular dystrophy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843366

Duchenne muscular dystrophy: the effect of glucocorticoids on ventilator use and ambulation

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843366

Prednisone 10 days on/10 days off in patients with Duchenne muscular dystrophy.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843366

Deflazacort use in Duchenne muscular dystrophy: an 8-year follow-up

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843366

Prednisolone in Duchenne muscular dystrophy with imminent loss of ambulation.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843366

Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843366

Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843366

Prednisolone therapy in Duchenne muscular dystrophy prolongs ambulation and prevents scoliosis

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843366

Early corticosteroid treatment in 4 Duchenne muscular dystrophy patients: 14-year follow-up

2 September 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3843366

2 October 2018

https://api.crossref.org/works/10.1007%2FS00415-013-7104-Y

Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy

21 January 2018

1 reference

12 December 2020

Evidence-based path to newborn screening for Duchenne muscular dystrophy

1 reference

12 December 2020

Deflazacort in Duchenne dystrophy: study of long-term effect

1 reference

12 December 2020

Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy

1 reference

12 December 2020

Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group

1 reference

12 December 2020

Prednisone in Duchenne muscular dystrophy

1 reference

12 December 2020

10.1007/S00415-013-7104-Y

Identifiers

DOI

1 reference

19 August 2017

1 reference

19 August 2017

1 reference